Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Other Liabilities

Amneal Pharmaceuticals Inc Other Liabilities Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Other Liabilities from 2016 to 2018.
  • Amneal Pharmaceuticals Inc Other Liabilities for the quarter ending December 12, 2018 was $233m a 90.39% increase of 210m year over year
  • Amneal Pharmaceuticals Inc Other Liabilities for the last 12 months ending December 12, 2018 was $233m a 90.39% increase of 210m year over year
  • Amneal Pharmaceuticals Inc Annual Other Liabilities for 2018 was $233m a 89.48% increase of 208m from 2017
  • Amneal Pharmaceuticals Inc Annual Other Liabilities for 2017 was $25m a 62.44% increase of 15m from 2016
  • Amneal Pharmaceuticals Inc Annual Other Liabilities for 2016 was $9m a 0.18% increase of 0m from 2015
Other Balance Sheet Metrics:
  • Amneal Pharmaceuticals Inc Total Assets for the quarter ending December 12, 2018 was $4,353m a 68.78% increase of 2,994m year over year
  • Amneal Pharmaceuticals Inc Total Equity for the quarter ending December 12, 2018 was $896m a 141.15% increase of 1,265m year over year
View Chart On Koyfin

Quarterly AMRX Other Liabilities Data

12/2018$233m
09/2018$242m
06/2018$243m
03/2018$22m
12/2017$25m
09/2017$8m
12/2016$9m

Annual AMRX Other Liabilities Data

2018$233m
2017$25m
2016$9m
2015$9m